Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.60 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.41 |
| ▸ | ARG2 | P78540 | 4/20 | 0.38 |
| ▸ | ARG1 | P05089 | 3/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8931572 | 1.00 | GSR (0.60) | GSRRNPEPCPB2ARG2ARG1 | |
| SCHEMBL18043462 | 0.92 | GSR (0.51) | GSRRNPEPCPB2GNAI3GNAO1 | |
| SCHEMBL4349577 | 0.91 | GSR (0.50) | GSRRNPEPCPB2GNAI3GNAO1 | |
| SCHEMBL2887202 | 0.90 | GSR (0.53) | GSRRNPEPCPB2ARG2ARG1 | |
| SCHEMBL28081220 | 0.90 | GSR (0.49) | GSRRNPEPCPB2DPP4DPP9 | |
| SCHEMBL28081209 | 0.90 | GSR (0.49) | GSRRNPEPCPB2DPP4DPP9 | |
| SCHEMBL4271001 | 0.89 | GSR (0.49) | GSRRNPEPCPB2GNAI3GNAO1 | |
| SCHEMBL18043461 | 0.89 | GSR (0.51) | GSRRNPEPCPB2ARG2ARG1 | |
| SCHEMBL30019601 | 0.89 | ALOX15 (0.49) | GSRRNPEPCPB2DPP4DPP8 | |
| SCHEMBL20489341 | 0.88 | GSR (0.55) | GSRRNPEPCPB2ARG2ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2793828-B1 | MOISTURIZING COMPOSITION COMPRISING AN AMINOPEPTIDE MIXTURE | UNILEVER PLC (GB) | 2016-08-24 | — | — | EP | claimed |
| CN-104302271-A | Moisturizing composition comprising an aminopeptide mixture | UNILEVER NV | 2015-01-21 | — | — | CN | claimed |
| EP-2793828-A2 | MOISTURIZING COMPOSITION COMPRISING AN AMINOPEPTIDE MIXTURE | Unilever PLC, a company registered in England and Wales under company no. 41424 (GB) | 2014-10-29 | — | — | EP | claimed |
| WO-2013092050-A2 | MOISTURIZING COMPOSITION COMPRISING AN AMINOPEPTIDE MIXTURE | UNILEVER PLC (GB) | 2013-06-27 | — | — | WO | claimed |
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | Leading Edge Innovations, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| WO-2024137539-A9 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF | Leading Edge Innovations, LLC (US) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024137566-A9 | SPRAYABLE SUNSCREEN COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-10-03 | — | — | WO | disclosed |
| US-20240207184-A1 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024137566-A1 | SPRAYABLE SUNSCREEN COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024137405-A1 | OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20240207185-A1 | OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207144-A1 | OIL-IN-WATER DESPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-05-13 | — | — | US | disclosed |
| EP-0768898-B1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AG (DE) | 2003-04-09 | — | — | EP | disclosed |
| US-20020187101-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | SCHERING AG (DE) | 2002-12-12 | — | — | US | disclosed |
| US-6426059-B1 | NUCLEAR MAGNETIC RESONANCE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2002-07-30 | — | — | US | disclosed |
| US-6248306-B1 | MEDICAL DIAGNOSIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-06-19 | — | — | US | disclosed |
| US-6177060-B1 | NMR OR X-RAY LYMPHOGRAPHY IMAGES | SCHERING AKTIENGESEUSCHAFT (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0768898-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-23 | — | — | EP | disclosed |
| WO-1996001655-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | ZYX, CCNY, MOK | GSR 1906/4885RNPEP 824/4885CPB2 2465/4885 |
| US-20020187101-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | TFPI, LYN, SYK | GSR 4107/4885RNPEP 2770/4885CPB2 2480/4885 |
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | LIPA, MGLL, SGMS2 | GSR 937/4885RNPEP 1483/4885CPB2 3082/4885 |
| US-20240207184-A1 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | HTT, LIPA, PIGS | GSR 4341/4885RNPEP 4155/4885CPB2 4761/4885 |
| US-20240207185-A1 | OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF | LIPA, LIPC, MGLL | GSR 475/4885RNPEP 2724/4885CPB2 3220/4885 |
| US-20240207144-A1 | OIL-IN-WATER DESPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | HTT, LIPA, PIGS | GSR 3068/4885RNPEP 4337/4885CPB2 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.